Synlogic, Inc. (SYBX) financial statements (2020 and earlier)

Company profile

Business Address 301 BINNEY STREET
CAMBRIDGE, MA 02142
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:120123876090
Cash and cash equivalents2611581690
Short-term investments931112944 
Other undisclosed cash, cash equivalents, and short-term investments0(0)(0)  
Prepaid expense111  
Other current assets100  
Other undisclosed current assets120111
Total current assets:133124896191
Noncurrent Assets
Finance lease, right-of-use asset1
Operating lease, right-of-use asset17
Property, plant and equipment13151000
Long-term investments and receivables15    
Long-term investments15    
Restricted cash and investments1112 
Other noncurrent assets000  
Other undisclosed noncurrent assets8    
Total noncurrent assets:55161130
TOTAL ASSETS:1891401006491
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities67815
Accounts payable22304
Accrued liabilities45500
Employee-related liabilities   01
Taxes payable    0
Deferred revenue1
Debt200  
Deferred rent credit 0
Restructuring reserve   2 
Deferred revenue and credits1  
Contract with customer, liability0
Other undisclosed current liabilities   00
Total current liabilities:98936
Noncurrent Liabilities
Long-term debt and lease obligation23001 
Finance lease, liability0
Capital lease obligations001 
Operating lease, liability23
Liabilities, other than long-term debt 85  
Deferred revenue and credits5  
Deferred rent credit 8
Total noncurrent liabilities:23861 
Total liabilities:32161546
Stockholders' equity
Stockholders' equity attributable to parent157124856085
Common stock00000
Additional paid in capital328244157163162
Accumulated other comprehensive income (loss)0(0)(0)(0) 
Accumulated deficit(171)(120)(72)(103)(77)
Total stockholders' equity:157124856085
TOTAL LIABILITIES AND EQUITY:1891401006491

Income statement (P&L) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Gross profit:232  
Operating expenses(57)(54)(43)(27)(25)
Operating loss:(54)(51)(41)(27)(25)
Nonoperating income33000
Investment income, nonoperating33100
Interest and debt expense(0)(0)(0)  
Loss from continuing operations before income taxes:(51)(48)(40)(26)(25)
Income tax expense (0)   
Loss before gain (loss) on sale of properties:(51)(49)(40)(26)(25)
Other undisclosed net income00   
Net loss:(51)(48)(40)(26)(25)
Other undisclosed net income attributable to parent  0  
Net loss attributable to parent:(51)(48)(40)(26)(25)
Preferred stock dividends and other adjustments    (4)
Net loss available to common stockholders, diluted:(51)(48)(40)(26)(29)

Comprehensive Income ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Net loss:(51)(48)(40)(26)(25)
Other comprehensive loss   (0) 
Comprehensive loss:(51)(48)(40)(26)(25)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent0(0)0  
Comprehensive loss, net of tax, attributable to parent:(51)(48)(40)(26)(25)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: